Dr. Davis on Comparisons Between Robotic Surgery and Open Surgery in Lung Cancer

Video

J. Russell Davis, MD, clinical professor, University of Missouri–Kansas City School of Medicine, thoracic surgeon, Saint Luke's Hospital, compares the use of robotic surgery with open surgery in patients with lung cancer.

J. Russell Davis, MD, clinical professor, University of Missouri—Kansas City School of Medicine, thoracic surgeon, Saint Luke's Hospital, compares the use of robotic surgery with open surgery in patients with lung cancer.

The use of robotic surgery, specifically robotic-assisted lobectomy and video-assisted thoracic surgery (VATS), is enabling physicians to deliver better surgical outcomes to patients with lung cancer, explains Davis. Several studies have shown that surgeons can do a better lymph node dissection with robotic surgery compared with an open surgery. The more lymph nodes that can be successfully taken out during surgery, the better oncologists can stage and subsequently treat patients.

Both robotic-assisted lobectomy and VATS have shorter lengths of stay compared with an open lobectomy, adds Davis. In terms of prognosis, VATS is also associated with a better survival compared with an open lobectomy. Overall, robotic surgery—whether robotic-assisted or video-assisted—is cosmetically much more appealing than an open thoracotomy.

Related Videos
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center